Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10184 Triple Negative Breast Neoplasms 1046 Neoplasms 574 Ovarian Neoplasms 564 Neoplasm Metastasis 515 Colorectal Neoplasms 473 Carcinoma, Non-Small-Cell Lung 468 Prostatic Neoplasms 440 Lung Neoplasms 433 Pancreatic Neoplasms 312 Melanoma 299 Stomach Neoplasms 295 Breast Neoplasms, Male 257 Motor Activity 252 Colonic Neoplasms 238 Uterine Cervical Neoplasms 227 Endometrial Neoplasms 223 Head and Neck Neoplasms 218 Carcinoma, Intraductal, Noninfiltrating 217 Carcinoma, Renal Cell 192 Squamous Cell Carcinoma of Head and Neck 181 Sarcoma 177 Urinary Bladder Neoplasms 159 Esophageal Neoplasms 155 Brain Neoplasms 155 Breast Carcinoma In Situ 154 Lymphedema 148 Fatigue 136 Carcinoma, Ovarian Epithelial 134 Small Cell Lung Carcinoma 130

Interventions

Pregabalin 1 Capsaicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Patient × Breast × Clear all

NCT03794388 2026-05-05

CAPTRANE

Institut Cancerologie de l'Ouest

Phase 3 Completed

140 enrolled 6 charts

Breast Cancer Patient

Data powered by HemOnc (CC BY 4.0) Colophon ⚡